EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The biotoxin BMAA promotes dysfunction via distinct mechanisms in neuroblastoma and glioblastoma cells

Bryan Burton, Kate Collins, Jordan Brooks, Karly Marx, Abigail Renner, Kaylei Wilcox, Ellie Moore, Keith Osowski, Jordan Riley, Jarron Rowe, Matthew Pawlus iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0278793 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Bryan Burton und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Natural Sciences, Black Hills State University, Spearfish, South Dakota, United States of America. Hauptthemen laut MEDLINE: Glioblastoma, Amyotrophic Lateral Sclerosis, Amino Acids, Diamino, Parkinsonian Disorders. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic exposure to the Cyanobacteria biotoxin Beta-methylamino-L-alanine (BMAA) has been associated with development of a sporadic form of ALS called Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex (ALS/PDC), as observed within certain Indigenous populations of Guam and Japan. Studies in primate models and cell culture have supported the association of BMAA with ALS/PDC, yet the pathological mechanisms at play remain incompletely characterized, effectively stalling the development of rationally-designed therapeutics or application of preventative measures for this disease. In this study we demonstrate for the first time that sub-excitotoxic doses of BMAA modulate the canonical Wnt signaling pathway to drive cellular defects in human neuroblastoma cells, suggesting a potential mechanism by which BMAA may promote neurological disease. Further, we demonstrate here that the effects of BMAA can be reversed in cell culture by use of pharmacological modulators of the Wnt pathway, revealing the potential value of targeting this pathway therapeutically. Interestingly, our results suggest the existence of a distinct Wnt-independent mechanism activated by BMAA in glioblastoma cells, highlighting the likelihood that neurological disease may result from the cumulative effects of distinct cell-type specific mechanisms of BMAA toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaAmyotrophic Lateral SclerosisAmino Acids, DiaminoParkinsonian DisordersNeuroblastomaAnimalsHumansCyanobacteria ToxinsNeurotoxins

Substanzen

beta-N-methylamino-L-alanineCyanobacteria ToxinsAmino Acids, DiaminoNeurotoxins

Autor:innen und Institutionen

  • Department of Natural Sciences, Black Hills State University, Spearfish, South Dakota, United States of America.
  • Department of Biology, University of Sioux Falls, Sioux Falls, South Dakota, United States of America.

ORCID-Profile: Matthew Pawlus

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Burton, B., Collins, K., Brooks, J., Marx, K., Renner, A., Wilcox, K., Moore, E., Osowski, K., Riley, J., Rowe, J., & Pawlus, M. (2023). The biotoxin BMAA promotes dysfunction via distinct mechanisms in neuroblastoma and glioblastoma cells. PLOS ONE. https://doi.org/10.1371/journal.pone.0278793

Vancouver

Burton B, Collins K, Brooks J, Marx K, Renner A, Wilcox K, et al. The biotoxin BMAA promotes dysfunction via distinct mechanisms in neuroblastoma and glioblastoma cells. PLOS ONE. 2023. doi:10.1371/journal.pone.0278793

BibTeX
@article{Burton2023,
  author = {Burton, Bryan and Collins, Kate and Brooks, Jordan and Marx, Karly and Renner, Abigail and Wilcox, Kaylei and Moore, Ellie and Osowski, Keith and Riley, Jordan and Rowe, Jarron and Pawlus, Matthew},
  title = {The biotoxin BMAA promotes dysfunction via distinct mechanisms in neuroblastoma and glioblastoma cells},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0278793}
}
Kostenlos starten →